secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2025-09-17T23:59:59+00:00
Accession:  0001193125-25-205553
Event type: other
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma announces 1-for-20 reverse stock split effective Sept 18, 2025
----------------------------------------------------------------------------

- Reverse stock split at 1-for-20 ratio effective 5:00 p.m. ET on September 18, 2025.
- Pre-split shares ~136.8M; post-split ~6.84M (subject to fractional share cash-out).
- Split-adjusted trading on Nasdaq begins September 19, 2025; new CUSIP 929033207.
- Proportionate adjustments to exercise prices and shares under equity plans and warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525205553/0001193125-25-205553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525205553/d945826d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-205553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer